Viet
ELITE MEMBER
- Joined
- Jun 18, 2012
- Messages
- 29,950
- Reaction score
- 0
- Country
- Location
Doses enter Phase 3 trials, but Hanoi could approve emergency use as cases climb
A Vietnamese health care worker administers the Nanocovax vaccine candidate, which has entered the final phase of clinical trials. (Photo by Vietnam News Agency)
TOMOYA ONISHI, Nikkei staff writerJune 15, 2021 00:04 JST
To continue reading, subscribe today
12:06 a.m. Vietnam's domestically developed coronavirus vaccine candidate begins Phase 3 clinical trials, with the country hoping to package doses for market by the end of the year.
Nanocovax started the final trials with 13,000 people participating, said vaccine developer Nanogen Pharmaceutical Biotechnology. The company is preparing to mass-produce the vaccine, with the capacity to turn out roughly 100 million doses a year at facilities in Ho Chi Minh City.
A police officer patrols in Ho Chi Minh City. Vietnam's southern commercial hub has extended a set of social restrictions. © Reuters
asia.nikkei.com
A Vietnamese health care worker administers the Nanocovax vaccine candidate, which has entered the final phase of clinical trials. (Photo by Vietnam News Agency)
TOMOYA ONISHI, Nikkei staff writerJune 15, 2021 00:04 JST
To continue reading, subscribe today
12:06 a.m. Vietnam's domestically developed coronavirus vaccine candidate begins Phase 3 clinical trials, with the country hoping to package doses for market by the end of the year.
Nanocovax started the final trials with 13,000 people participating, said vaccine developer Nanogen Pharmaceutical Biotechnology. The company is preparing to mass-produce the vaccine, with the capacity to turn out roughly 100 million doses a year at facilities in Ho Chi Minh City.
Vietnam homegrown COVID vaccine heads for full approval by year-end
Doses enter Phase 3 trials, but Hanoi could approve emergency use as cases climb
asia.nikkei.com
